Untitled Document
OHSU Where Healing, Teaching and Discovery Come Together
OHSU Search OHSU OHSU Site Map Contact
OHSU Division of Hematology and Medical Oncology
About the Division Care Centers Patient Resources Our Faculty Research and Education News and Events
Dedicated to the study and treatment of cancer and disorders of the blood.

 
undefined

Our Faculty

Tibor Kovacsovics, M.D.
Associate Professor of Medicine

Specialty: Hematology/Oncology

Clinic Phone: 503-494-5058
Office Phone: 503-494-1551
E-mail: kovacsov@ohsu.edu

 

Dr. Kovacsovics' clinical focus is the management of hematological malignancies by conventional chemotherapy and stem cell transplantation; his research focus is acute leukemia. He received his medical degree from the University of Geneva Medical School, Switzerland and completed a Hematology/Oncology fellowship at Brigham and Women's Hospital, Brigham and Women's Hospital, MA. He joined OHSU in 2004.

 
Appointments

  • 1990-1994 Research Fellow in Medicine, Harvard Medical School
  • 1990-1991 Clinical Research Fellow in Medicine, Hematology-Oncology, Massachusetts General Hospital, Boston
  • 1991-1994 Clinical Research Fellow in Medicine, Hematology-Oncology, Brigham and Women's Hospital, Boston
  • 1994-1996 Chef de clinique in the Division of Hematology, Lausanne University Hospital
  • 1996-2004 Medecin associe in the Division of Hematology, Lausanne University Hospital
  • 2004 Oregon Health and Science University

 

Professional Education and Training

Education
  • 1981 M.D. University of Geneva Medical School

Postdoctoral Training

Research

  • 1982-1985 Research Assistant, Institute of Biochemistry, University of Lausanne
Internships and Residencies
  • 1985-1988 Resident in Internal Medicine, Clinique Medicale Therapeutique, Geneva University Hospital
  • 1988- 1990 Chief Resident in Internal Medicine, Clinique Medicale Therapeutique, Geneva University Hospital
Fellowships
  • 1990-1991 Clinical and Research Fellow in Medicine, Hematology-Oncology, Massachusetts General Hospital, Boston
  • 1991-1994 Clinical Research Fellow in Medicine, Hematology-Oncology, Brigham and Women's Hospital, Boston

 

Personal


Other


 
Selected Publications

  • L?wenberg B, van Putten W, Gm?r J, Theobald M, Verdonck L, Sonneveld P, Fey M, Schouten H, Ferrant A, Kovacsovics T, Gratwohl A, Daanen S, Huijgens P, Boogaerts M. Effect of priming with granulocyte-colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 2003 ; 349 :743
  • Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N, Kovacsovics T, Delannoy A, Fegueux N, Fenaux P, Stamatoullas A, Vernant JP, Tournilhac O, Buzyn A, Reman O, Charrin C, Boucheix C, Gabert J, Lh?ritier V, Fi?re D. Outcome of treatment in 922 adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trial. J Clin Oncol 2004 ; 22 :4075.
  • Keating MJ, Cazin B, Coutr? S, Birhiray R, Kovacsovics T, Langer B, Leber C, Maughan T, Rai K, Tj?nnfjord, Bekradda, Itzhaki M, Herait P. Campath-1H treatment in T-cell prolymphocytic leukemia (T-cell PLL) patients who have failed at least one prior chemotherapy. J Clin Oncol 2002 ; 20: 205
  • Kovacsovics TJ, Bachelot C, Toker A, Vlahos CJ, Duckworth B, Cantley LC, Hartwig JH. Phosphopinositide 3-kinase inhibition spares actin assembly in activating platelets, but reverses platelet aggregation. J Biol Chem 1995;270: 11358
  • Hauert J, Fernandez-Carneado J, Mathieu S, Grell D, Schapira M, Spertini O, Tuscherer G, Kovacsovics T. Inhibition of botrocetin-induced platelet aggregation by a template-assembled synthetic protein (TASP) based on the structure of von Willebrand factor A1 domain. ChemBioChem 2004 ; 5 :856

Search PubMed for more publications